Posts

Posted on

Avast launches private browser for iOS and cross-platform synchronization

Avast Secure Browser adds support for iOS, brand new cross-platform syncing and full data encryption

PR Newswire

LONDON and REDWOOD CITY, Calif., Nov. 17, 2020 /PRNewswire/ — Avast (LSE:AVST), a global leader in digital security and privacy products, has launched an iOS version of Avast Secure Browser (ASB) to add to its multi-platform portfolio which also includes support for Windows, Mac and Android. The 2020 ambition to become a multi-platform browser is part of ASB’s ongoing focus to converge security and privacy services to enable a safer, more private and faster browsing experience across devices and operating systems.

The introduction of the mobile browser for iOS is one of two major updates offered in the latest release, code-named ‘Rainier’. ASB customers now have the ability to sync browsing history and bookmarks between platforms from their Avast account, delivering an all-in-one and frictionless secure browsing experience. The Cross Platform Sync feature applies to both desktop* and mobile devices and utilizes end-to-end encryption to ensure communications are secured and inaccessible to third parties throughout the syncing process.

Scott Curtiss, Vice President and General Manager of Avast Secure Browser, said, “Since launching Avast Secure Browser for Windows, our goal has been a multi-platform offering with built-in, centralized privacy tools and a syncing option that makes the concept of private and secure browsing approachable for users. Over the past year, we’ve introduced Avast Secure Browser for Android and now iOS to become a powerful multi-platform player with 35 million monthly active users across all platforms. Moving forward, our intent is to build on this momentum and utilize Avast’s expertise to integrate intuitive consumer friendly security and privacy services that go beyond the offerings of other household browsers.”

Similar to ASB for Android, the iOS version has been built from the ground up with full data encryption at its core. This includes AES-256 and the latest TLS/SSL cryptographic protocols for the data transport layer. Additional built-in security and privacy features available with Avast Secure Browser for iOS include:

  • A lightning fast VPN that encrypts all data in motion and at rest**
  • A media vault that stores and encrypts downloaded files
  • Anti-tracking technology that prevents websites, advertisers and other web services from tracking online activity
  • Built-in Adblock to improve website load time (browser speed)
  • Customizable browsing modes including Secure Mode, Secure & Private Mode, and Custom Mode

Avast Secure Browser for iOS supports iPhone, iPad and iPod on iOS 13.0 and above, and is available for download here.

* macOS Cross Platform Sync support coming later this month
**The free version of ASB for iOS includes unlimited VPN protection to the fastest server location for browsing traffic based on user location. Updating to Pro unlocks all 30+ locations and enables device-wide VPN protection for all mobile apps.

About Avast:
Avast (LSE: AVST), a FTSE 100 company, is a global leader in digital security and privacy products. With over 400 million users online, Avast offers products under the Avast and AVG brands that protect people from threats on the internet and the evolving IoT threat landscape. The company’s threat detection network is among the most advanced in the world, using machine learning and artificial intelligence technologies to detect and stop threats in real time. Avast digital security products for Mobile, PC or Mac are top-ranked and certified by VB100, AV-Comparatives, AV-Test, SE Labs and others. Visit: www.avast.com

Media Contact

[email protected]

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/avast-launches-private-browser-for-ios-and-cross-platform-synchronization-301174124.html

SOURCE Avast

Posted on

Belkin Announces BOOST↑CHARGE™ TrueFreedom PRO Wireless Charger

Delivers World’s First Qi-Certified Multi-Coil Wireless Charging Solution

PR Newswire

LOS ANGELES, Nov. 17, 2020 /PRNewswire/ — Belkin, the connected things division within the Belkin International and Foxconn Interconnect Technology (FIT) (HK:6088) entity, today unveils the BOOST↑CHARGE™ TrueFreedom PRO Wireless Charger, the newest addition to its extensive portfolio of Qi-certified wireless charging solutions. A radical evolution beyond its core charging products, the TrueFreedom PRO continues Belkin’s tradition of award-winning wireless charging solutions, selling nearly 10 million units worldwide. Belkin made history with its first Boost↑Up Wireless Charging Pad for iPhone 8, iPhone 8 Plus and iPhone X, and the company’s dedication to people-inspired design and quality continues to inform the product lifecycle from user testing, regulatory compliance, manufacturing and warranty programs.

Designed and engineered in-house, the long-awaited, competitively-priced TrueFreedom PRO Wireless Charger offers full-surface charging, allowing consumers to simply place two Qi-enabled devices anywhere on the charging pad to receive 10W of fast wireless charging for each device at the same time. The TrueFreedom PRO houses 16 charging coils intelligently working together to provide consistent power to consumers’ Qi-certified phones or earbuds anywhere on the pad’s greater surface area, eliminating the need to perfectly align devices for effective charging.

“We’ve been delivering next generation technology since 1983 and participated in the conception of wireless charging,” says Steve Malony, senior vice president, Belkin International. “As an early and active member in the World Power Consortium, we have been thoughtfully engineering this product for some time to ensure that it is powerful, elegant and simply works the way wireless charging was originally imagined.”

Key features:

  • Qi-certified for safe, reliable wireless charging and seamless compatibility with all Qi-enabled devices from multiple manufacturers
  • True freedom of placement for effective and consistent charge anywhere on the pad’s greater surface area
  • Fast charging up to 10W per device offering optimal charging for Apple*, Samsung and other devices simultaneously
  • Case compatible to charge through most lightweight cases up to 3mm in thickness
  • Sophisticatedly designed with silver chrome accents and leather-like finish to elevate space and complement any room décor
  • Two LED lights to indicate charging status
  • 2-year Belkin warranty for added peace of mind

The BOOST↑CHARGE™ TrueFreedom PRO is now available for purchase at select retailers worldwide and coming soon to


Belkin.com


for $129.99 USD.

Imagery can be found here.

*The BOOST↑CHARGE™ TrueFreedom PRO optimally charges the iPhone 8, iPhone 8 Plus, iPhone X, iPhone XS, iPhone XS Max, iPhone XR, iPhone 11, iPhone 11 Pro, and iPhone 11 Pro Max

About Belkin

The Belkin brand is a market leader in accessories delivering power, protection, productivity and connectivity solutions for a broad range of consumer electronics and enterprise environments. Designed in Southern California, Belkin products include award-winning lines such as the Store and Charge Go business solution, SOUNDFORM™ audio portfolio, BOOST↑CHARGE™ mobile power collection, and SCREENFORCE™ screen protection. Belkin products are sold in more than 50 countries around the world, connecting people to the technology they love whether they are at home, at work or on the go.

About Belkin International

In 2018, Foxconn Interconnect Technology merged with Belkin International (Belkin®, Linksys®, Wemo®, Phyn®) to create a global consumer electronics leader. Today, this group leads in connecting people with technologies at home, at work and on the go within the accessories (“Connected Things” – Belkin brand) and the smart home (“Connected Home” – Linksys, Wemo and Phyn brands) markets.

© 2020 Belkin International, Inc. and/or its affiliates. All rights reserved.

All product names, logos, and brands are property of their respective owners.

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/belkin-announces-boostcharge-truefreedom-pro-wireless-charger-301174333.html

SOURCE Belkin International

Posted on

Cirium Sky – a new cloud solution provides an unrivaled 360-degree view of flight

Cirium Sky – a new cloud solution provides an unrivaled 360-degree view of flight

LONDON–(BUSINESS WIRE)–
A new managed cloud solution—Cirium Sky—has launched and provides the first 360-degree view of flights in real-time for the air operations sector.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201117005361/en/

Cirium Sky unifies data in a managed cloud and provides an unrivalled 360-degree view of flight in real-time for the air operations sector. (Graphic: Business Wire)

Cirium Sky unifies data in a managed cloud and provides an unrivalled 360-degree view of flight in real-time for the air operations sector. (Graphic: Business Wire)

Cirium Sky provides a single source of comprehensive aviation and air travel data which streamlines essential data-driven operations, planning and decision-making.

Thesolution leverages the vast portfolio of flight schedules, fleet, flight performance, aeronautical, system wide information management (SWIM), and traffic and fares datasets, derived from The Cirium Core – a unique mix of proprietary technologies, skills and processes at the heart of the business.

Cirium,the global aviation and air travel data and analytics company, combines data from The Cirium Core and critical contextual data that includes external factors, such as weather and air traffic control directives for more granular analytics and better operational control.

Ian Painter, VP of AirOps at Cirium said: “Cirium Sky, our first managed cloud solution, provides a wealth of data and historical and real-time intelligence in a single secure source to radically improve airlines business operations.

By breaking down data silos in the industry and improving the access to the data, businesses using Cirium Sky can broaden their analyses to include global, regional and competitor insights.

The impact of COVID-19 on air travel has made it more critical than ever for timely, accurate and complete information in a rapidly changing landscape.”

Cirium Sky is a suite of Data-Management-as-a-Service (DMaaS) offerings, meaning data management strategies which use the cloud to deliver data storage, integration, processing and analytics services.

Cirium can relieve industry analysts of the time-consuming and costly process of gathering, cleaning, hosting and managing data. This enables organizations to take charge of their in-house analytics and supports all the major business intelligence tools.

This initial launch of Cirium Sky for air operations is only the first part of Cirium’s cloud-based innovation. The company will soon roll out tailored versions of Cirium Sky to key market segments within aviation.

Click here to find out more about Cirium Sky.

Ends

For further information please visit www.cirium.com and follow Cirium updates via LinkedIn and Twitter.

About Cirium

Cirium brings together powerful data and analytics to keep the world moving. Delivering insight, built from decades of experience in the sector, enabling travel companies, aircraft manufacturers, airports, airlines and financial institutions, among others, to make logical and informed decisions which shape the future of travel, growing revenues and enhancing customer experiences. Cirium is part of RELX, a global provider of information-based analytics and decision tools for professional and business customers.

Find out more at cirium.com.

For media enquiries, please contact: [email protected]

Rachel Humphries, Cirium (Global), Tracy Cheung, Cirium (Asia-Pacific)

PC Agency (EMEA) at [email protected] or Juliett Alpha (US) at [email protected]

KEYWORDS: South America Central America North America Canada Europe United States Middle East United Kingdom

INDUSTRY KEYWORDS: Software Transportation Internet Travel Data Management Technology Air Transport

MEDIA:

Logo
Logo
Photo
Photo
Cirium Sky unifies data in a managed cloud and provides an unrivalled 360-degree view of flight in real-time for the air operations sector. (Graphic: Business Wire)
Posted on

Ascendant Announces Expansion into the UK

TORONTO and LONDON, Nov. 17, 2020 (GLOBE NEWSWIRE) — Ascendant today announced the expansion of their global operations with an entry into the UK market. The financial technology and global payments provider will focus on growing their corporate client base and valued partnerships by offering technology-driven payment solutions that save customers time and money as they navigate a challenging economic environment.

“Having the infrastructure and operational capabilities to expand into the UK market is a significant and strategic milestone for our company,” said Jason Mugford, President and Chief Executive Officer at Ascendant. “We see a strong opportunity to help UK companies protect margins and drive efficiency in the face of renewed lockdowns. I’m proud of our team for placing us in such a strong position that we are able to increase our market footprint.”

Ascendant helps clients build business resilience with payment solutions that identify opportunities for increased operational efficiency. As members of the SWIFT network and Global Payment Initiative (gpi), Ascendant improves payment delivery and provides greater transparency for customers. Ascendant’s World Virtual Accounts also enable businesses to send and receive payments in hundreds of currencies without needing a local area presence.

Research by Velocity Global identified a 25% increase in inquiries from businesses interested in European expansion this year as firms look abroad for revenue and profit growth opportunities. Ascendant will support clients’ international businesses by offering more reliable, efficient, and cost-effective payment solutions that protect against market uncertainty and volatility.

Tony Crivelli, Chief Growth Officer at Ascendant, added, “Our team of experienced professionals are ready to bring our market-leading technology to help UK businesses find unrealized operational efficiencies at a time when they are sorely needed. Our client-driven solutions will help customers build business resilience through these tough economic times and beyond.”

For over a decade, Ascendant has worked with large corporations and over 2,000 financial institutions in North America, providing customized solutions to track and send global payments with ease while protecting customer data. To learn more, please visit www.ascendant.world.

About Ascendant

Ascendant is a worldwide provider of technology-based payment solutions. Ascendant is founded on the principles of delivering value beyond price with customer driven innovation and tailor-made solutions that help customers build business resilience. Gain a 360-degree view of your business payments with our team of experienced specialists and smart, cost-effective solutions designed to support business growth and build operational efficiency.

Media Contact:

Megan Kent
Magnolia Marketing Communications
E: [email protected]
M: +1 613-620-9378



Posted on

Lumissil introduces a Family of Industry-Leading Capacitive-Touch Sense Controllers

IS31SE5117 & IS31SE5118 provide State-of-the-art Sigma Delta Cap-Touch Technology with Shield Drive Moisture Control and very low Power Consumption

MILPITAS, Calif., Nov. 17, 2020 (GLOBE NEWSWIRE) — LUMISSIL MICROSYSTEMS, a Division of ISSI, today announced a new family of capacitive touch sensor controllers consisting of IS31SE5117 & IS31SE5118 which simplify the replacement of mechanical buttons in a variety of applications such as home appliances, IoT devices, instrumentation and control panels and liquid level measurement devices. To enable easy prototyping and rapid implementation into any product the software package comes complete with a standard code and calibration GUI.

“The new family of touch sensor controllers integrate a proprietary sigma delta enhanced dual-slope charge sharing capacitance touch technology with up to 24 bit precision to provide high sensitivity and low noise performance,” said Ven Shan, VP of Marketing at Lumissil Microsystems. “Such performance is necessary where users wear gloves or surfaces have thick glass or air gaps as in home appliances. In addition, they consume very low average power and include an auto calibration feature that compensates for temperature and humidity changes and any false touch activation providing a superior value point for our customers.”

Both products are supplied as a turn-key product with a standard code. Applicable for variety of cap-touch sensors interfaces (button, wheel, slider and proximity) and materials (glass, plastics, wood etc.).

The development packages include documentation, evaluation boards and calibration GUIs that include a configuration tool. The calibration GUI enables simple device configuration in one flow for calibrating capacitive touch sensors, configuring GPIO ports and saving configuration directly to a file or target device’s flash, with no programing required. A GPIO can also be configured to output melody using on-chip melody/tone generator. Product debugging support is also available from ISSI’s application engineers.

Key features and
benefits

  • Capacitive touch sensors: IS31SE5117 –15 sensors; IS31SE5118 – 11 sensors.
  • Differential Dual-slope charge sharing – up to 24-bit precision count.
  • Best in class Liquid Tolerance – Shield Driver available for all device Cap-touch sensors.
  • Individual sensors calibration & sensitivity thresholds; Auto-calibration included.
  • Available multiple-button-press and press-and-hold functionality.
  • Low Average power consumption – 5μA Quiescent current with Wake-on-touch feature.
  • 400kHz fast-mode I²C interface to host controller.
  • Invert or Toggle GPIO outputs by touch-sensors by configuration.
  • Melody/Tone output options.
  • Easy to use GUI required to calibrate and configure device for production.

Packaging and
Availability

IS31SE5117 is available in 24 pin QFN-24 package and IS31SE5118 in 16 pin TSSOP-16 package. They operate from 2.7V to 5.5V over a temperature range of -40°C to +105°C. Samples can be ordered through Lumissil’s global sales team and worldwide distribution partners.

The IS31SE5117-QFLS3-TR is available and priced at $0.43 in quantities of 10,000.

The IS31SE5118-SALS3-TR is available and priced at $0.42 in quantities of 10,000.

About Lumissil

Lumissil is the analog/mixed-signal product division of ISSI, a fabless semiconductor company that designs and markets high performance integrated circuits for the following key markets: (I) automotive, (ii) communications, (iii) industrial/medical, and (iv) digital consumer. Lumissil’s primary products are LED drivers for low to mid-power RGB color mixing and high power lighting applications. Other products include audio, sensor, high speed wired communications, optical networking ICs and Application-specific microcontrollers. ISSI/Lumissil is headquartered in Silicon Valley with worldwide offices in Taiwan, Japan, Singapore, China, Europe, Hong Kong, India, and Korea. Visit our web site at http://www.lumissil.com/ 

About Integrated Silicon Solution, Inc. (ISSI)

ISSI is a fabless semiconductor company that designs, develops and markets high performance SRAM, DRAM, Flash memory (including NOR flash, NAND flash and managed NAND solutions (eMMC)), and Analog/Mixed-signal integrated circuits. ISSI provides high-quality semiconductor products and has been a committed long-term supplier to its customers. ISSI is headquartered in Silicon Valley with worldwide offices in Taiwan, Japan, Singapore, China, Europe, Hong Kong, India, and Korea. Visit our web site at http://www.issi.com/ 

Ven Shan Lior Broner
P: 408-969-4622 P: 408-969-5128

[email protected]
[email protected]

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/22bbd7fe-2f07-4dca-83ba-150f9ebeae74



Posted on

Castellums fifth consecutive year on top in world’s leading sustainability index

PR Newswire

GÖTEBORG, Sweden, Nov. 17, 2020 /PRNewswire/ — The world’s foremost sustainability index ranks Castellum as global leader in sustainability – for the fifth consecutive year.

“We are extremely happy to be at the top of the podium again. It makes me very proud and I want to thank all employees for a fantastic effort “, says Henrik Saxborn, CEO of Castellum.

This year’s edition of the Dow Jones Sustainability Index evaluates and ranks the companies that perform best in the world on sustainability throughout all major industries. Castellum is the only Nordic real estate company and one of only seven Swedish companies that have qualified for the index – and with even higher ratings than last year.

“That we maintain our lead so persistently in this important context is proof that we are doing a really good job,” states Filip Elland, head of sustainability at Castellum. “It is a team effort carried out with equal parts commitment, competence and fighting spirit. Now the journey continues towards more challenging goals and with the ambition to remain among the best performers next year as well.”

Castellum’s main success factor is that sustainability is fully integrated into the business. For example, in 2020 we were one of the first real estate companies in the world to adopt roadmaps with concrete steps to achieve our Science Based Target goal of net-zero carbon dioxide emissions by 2030. We recently started northern Europe’s largest rooftop solar cell plant in our Hisingen Logistics Park, we are building the world’s first police facility made entirely of wood (aiming to achieve climate neutrality) and this summer we became first in Scandinavia with a WELL-certified office building, the only certification system that takes into account the health and well-being of those who work in a property.

“The Dow Jones Sustainability Index is utilized by institutional and financial investors to make decisions that contribute to a more sustainable real estate industry. Our goal is not to win prizes and medals, but to make the greatest possible effort to both secure long-term sustainable business and to counteract climate change that threatens the entire planet”, says Filip Elland.

For more information please contact:

Henrik Saxborn, VD Castellum AB, +46.31.607450

Filip Elland, hållbarhetschef Castellum, +46.703.206326

More about DJSI: https://www.spglobal.com/esg/csa/indices/djsi-index-family

About Castellum:

Castellum is one of Sweden’s largest listed real estate companies with a property value of SEK 98 billion. We are active in 17 Swedish growth regions as well as in Copenhagen and Helsinki. Every day, 250,000 people go to work in our premises. We develop flexible workplaces and logistics solutions in close proximity to city centres and with a lettable area of 4.3 million square meters. One of our sustainability goals is to be completely climate neutral by 2030. Castellum is the only Nordic real estate company selected by the Dow Jones Sustainability Index (DJSI). The Castellum share is listed on the Nasdaq Stockholm Large Cap.

Beyond expectations.
www.castellum.se

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/castellum/r/castellums-fifth-consecutive-year-on-top-in-world-s-leading-sustainability-index,c3238139

The following files are available for download:

 

Cision View original content:http://www.prnewswire.com/news-releases/castellums-fifth-consecutive-year-on-top-in-worlds-leading-sustainability-index-301174351.html

SOURCE Castellum

Posted on

IRRAS Awarded Breakthrough Technology Purchasing Agreement with Premier for Hummingbird ICP Monitoring Products

– Premier is one of the leading healthcare improvement companies in the United States, uniting an alliance of approximately 4,100 US hospitals and 200,000 providers.

– Hummingbird family of products are now available to Premier’s member facilities in the US as contracted items with pre-negotiated pricing and terms.

PR Newswire

STOCKHOLM, Nov. 17, 2020 /PRNewswire/ — IRRAS AB, a commercial-stage medical technology company with a comprehensive portfolio of innovative products for neurocritical care, today announced that its Hummingbird family of intracranial pressure (ICP) monitoring equipment has been awarded a group purchasing agreement with Premier Inc. in the United States. Effective December 1, the new agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for Hummingbird ICP Monitoring products.

Premier added the Hummingbird products to its list of contractually approved items in the neurosurgical critical care product category via its Technology Breakthroughs program. This selective program allowed IRRAS to gain status as an approved supplier outside of Premier’s normal contract cycle.

“Today’s announcement is a significant accomplishment for the commercial growth of IRRAS,” said Will Martin, IRRAS’ President and Chief Commercial Officer. “This contract accelerates our US Hummingbird launch by allowing our team to introduce the product to Premier’s broad membership group of approximately 4,100 hospitals.”

Assessment of a patient’s ICP is a critical element of managing traumatic brain injury, and the Hummingbird product family is designed to continuously monitor a patient’s ICP by placing a small probe directly into the brain tissue. Instead of using strain gauge or fiberoptic sensors like other ICP monitors, the Hummingbird system uses a small air bladder that allows simple setup and automatic, hourly ICP recalibration. This air bladder mechanism of action eliminates challenges that plague other systems, including cumbersome setup and ICP readings that cannot be recalibrated and become increasingly inaccurate over time.

Premier is a leading healthcare improvement company, uniting an alliance of approximately 4,100 US hospitals and 200,000 other providers to transform healthcare. With integrated data and analytics, collaboratives, supply chain solutions, and advisory and other services, Premier enables better care and outcomes at a lower cost.

1.  Severe TBI. Centers for Disease Control and Prevention, Centers for Disease Control and Prevention, 2 Apr. 2019, www.cdc.gov/traumaticbraininjury/severe.html.

2.    Traumatic Brain Injury Fact sheets and Policy brief. Center-TBI, https://www.center-tbi.eu/files/news/21571f81-20b8-4860-a3dd-1f6e27d02b3d.pdf.

About IRRAS

IRRAS is a global medical care company focused on delivering innovative medical solutions to improve the lives of critically ill patients. IRRAS designs, develops, and commercializes neurocritical care products that transform patient outcomes and decrease the overall cost of care by addressing complications

associated with current treatment methodologies. IRRAS markets and sells its comprehensive, innovative IRRAflow and Hummingbird ICP Monitoring product lines to hospitals worldwide through its direct sales organization in the United States and select European countries as well as an international network of distribution partners.

IRRAS maintains its headquarters in Stockholm, Sweden, with corporate offices in Munich, Germany, and San Diego, California, USA. For more information, please visit www.irras.com.

IRRAS AB (publ) is listed on Nasdaq Stockholm (ticker: IRRAS).

For more information, please contact:
USA
Kleanthis G. Xanthopoulos, Ph.D.
CEO
[email protected] 
Europe
Sabina Berlin
CFO
+46 73 951 95 02
[email protected]

The information was released for public disclosure, through the agency of the contact person above, on November 17, 2020 at 08:00 (CET).

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/irras/r/irras-awarded-breakthrough-technology-purchasing-agreement-with-premier-for-hummingbird-icp-monitori,c3238184

 

Cision View original content:http://www.prnewswire.com/news-releases/irras-awarded-breakthrough-technology-purchasing-agreement-with-premier-for-hummingbird-icp-monitoring-products-301174340.html

SOURCE IRRAS

Posted on

AlzeCure publishes its interim report for January – September 2020

PR Newswire

STOCKHOLM, Nov. 17, 2020 /PRNewswire/ — AlzeCure Pharma AB (publ) (FN STO: ALZCUR) today announced that its interim report for the period January – September 2020 is now available on the company’s website: https://www.alzecurepharma.se/en/section/investors/financial-reports/

“AlzeCure has had another productive quarter during which its operations progressed according to plan, with advances in all three of our project platforms: NeuroRestore, Alzstatin and Painless. Preparations to begin two additional clinical trials at the end of the year for the drug candidates ACD856 and ACD440 are proceeding according to plan.”

Martin Jönsson, CEO

Financial information for July – September, 2020

Figures in parentheses refer to the corresponding period of the previous year.

  • Net sales during the period totaled SEK 0 thousand (0).
  • Earnings for the period totaled SEK -21,455 thousand (-13,382).
  • Earnings per share, basic, totaled SEK -0.57 (-0.35).
  • Total assets at the end of the period amounted to SEK 138,334 thousand (201,596).
  • Cash and cash equivalents at the end of the period totaled SEK 132,976 thousand (196,842).

Financial information for January – September, 2020

Figures in parentheses refer to the corresponding period of the previous year

  • Net sales during the period totaled SEK 0 thousand (0).
  • Earnings for the period totaled SEK -53,646 thousand (-35,223).
  • Earnings per share, basic, totaled SEK -1.42 (-0.93).
  • Total assets at the end of the period amounted to SEK 138,334 thousand (201,596).
  • Cash and cash equivalents at the end of the period totaled SEK 132,976 thousand (196,842).

Significant events during the period January – June, 2020

  • In January, the company in-licensed a new project, ACD440, which focuses on neuropathic pain and is in clinical development phase.
  • Martin Jönsson was appointed to serve as the new Chief Executive Officer on January 8, 2020. Martin has worked in the global pharmaceutical industry for more than 20 years, with extensive experience from various executive positions at both Ferring Pharmaceutical and Roche.
  • Johan Sandin took over the position of Chief Scientific Officer in January, which enabled him to dedicate all of his time to research and development.
  • An van Es Johansson joined the management group in March as Head of Development & Chief Medical Officer and thereby stepped down from the Board of Directors. This arrangement further strengthens the company in a period when it is developing and preparing to increase the number of clinical trials, in line with previously announced plans.
  • On April 2 the company presented a “late-breaking abstract” at the Advances in Alzheimer’s and Parkinson’s Therapies (AAT-AD/PD) conference. Dr. Pontus Forsell, Head of Discovery, and lead author of the study, gave an oral presentation entitled “ACD856 a positive modulator of neurotrophin signaling reverses scopolamine- or age-induced cognitive deficits”. The study shows that treatment with ACD856 results in potent memory enhancement in preclinical studies.
  • On June 4, the company presented favorable data from the first clinical trial with ACD856, which showed that ACD856 has a good pharmacokinetic profile with a significantly shorter half-life in humans than its predecessor, ACD855, and that the candidate is suitable for further clinical development as an oral therapy for conditions such as Alzheimer’s disease.

Significant events during the period July – September, 2020

  • During the quarter the company was represented and active in various events, including scientific symposiums focused on Alzheimer’s disease arranged with Professor Bengt Winblad at Karolinska Institutet, as well as professor Henrik Zetterberg, active at University College London in the UK and the University of Gothenburg.

Significant events after the end of the period

  • AlzeCure Pharma received on November 12, approval to start clinical Phase I trial with ACD856 in Alzheimer’s disease.

Read the full report at: https://www.alzecurepharma.se/en/section/investors/financial-reports/

The information was submitted for publication, through the agency of the contact person set out below at 08.00 am CET on November 17, 2020. 

For more information, please contact

Martin Jönsson, CEO
Tel: +46 (0)70-786 94 43
E-mail: [email protected]

About AlzeCure Pharma AB (publ)

AlzeCure® is a Swedish pharmaceutical company that develops new innovative drug therapies for the treatment of severe diseases and conditions that affect the central nervous system, such as Alzheimer’s disease and pain – indications for which currently available treatment is extremely limited. The company is listed on Nasdaq First North Premier Growth Market and is developing several parallel drug candidates based on three research platforms: NeuroRestore®, Alzstatin® and Painless.

NeuroRestore consists of three symptomatic drug candidates where the unique mechanism of action allows for multiple indications, including Alzheimer’s disease, as well as cognitive disorders associated with traumatic brain injury, sleep apnea and Parkinson’s disease. Alzstatin comprises two disease-modifying and preventive drug candidates for early treatment of Alzheimer’s disease. Painless is the company’s research platform in the field of pain and contains two projects: ACD440, which is a clinical candidate for the treatment of neuropathic pain, and TrkA-NAM, which targets severe pain in conditions such as osteoarthritis. AlzeCure aims to pursue its own projects through preclinical research and development to an early clinical phase and is continuously working with business development to find suitable out-licensing solutions with other pharmaceutical companies.

FNCA Sweden AB, +46(0)8 528 00 399 [email protected] , is the company’s Certified Adviser. For more information, please visit www.alzecurepharma.se.

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/alzecure-pharma-ab/r/alzecure-publishes-its-interim-report-for-january—september-2020,c3237686

The following files are available for download:

 

Cision View original content:http://www.prnewswire.com/news-releases/alzecure-publishes-its-interim-report-for-january–september-2020-301174338.html

SOURCE AlzeCure Pharma AB

Posted on

AAK’s Capital Market Day 2020

PR Newswire

KARLSHAMN, Sweden, Nov. 17, 2020 /PRNewswire/ — Today, AAK is hosting its annual Capital Market Day for analysts, investors and media representatives.

At this year’s event, held virtually due to the Covid-19 pandemic, AAK’s President and CEO Johan Westman together with Fredrik Nilsson, CFO, and Anne Mette Olesen, Chief Strategy and Sustainability Officer, update the financial market and media on the company’s purpose, strategy and business, financial development, and progress within the sustainability area.

In addition, Sten Estrup, President Asia, presents AAK’s development in Asia, and Niall Sands, President Plant-based Foods, gives an update on the company’s solutions for plant-based products.

All presentations are available on www.aak.com/cmd. A live Q&A webcast with all presenters will be held later today, from 2:00 to 3:00 p.m. CET. A recording of the Q&A webcast will be published on www.aak.com/cmd after the event.

For further information, please contact:

Fredrik Nilsson
 

CFO
Mobile: +46 708 95 22 21
E-mail: [email protected]

The information was submitted for publication at 8:00 a.m. CET on November 17, 2020.

AAK is a leading provider of value-adding vegetable oils & fats. Our expertise in lipid technology within foods and special nutrition applications, our wide range of raw materials and our broad process capabilities enable us to develop innovative and value-adding solutions across many industries – Chocolate & Confectionery, Bakery, Dairy, Plant-based Foods, Special Nutrition, Foodservice, Personal Care, and more. AAK’s proven expertise is based on more than 140 years of experience within oils & fats. Our unique co-development approach brings our customers’ skills and know-how together with our own capabilities and mindset for lasting results. Listed on Nasdaq Stockholm and with our headquarters in Malmö, Sweden, AAK has more than 20 different production facilities, sales offices in more than 25 countries and more than 3,900 employees.We are AAK – The Co-Development Company.

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/aak-ab/r/aak-s-capital-market-day-2020,c3238049

The following files are available for download:

 

Cision View original content:http://www.prnewswire.com/news-releases/aaks-capital-market-day-2020-301174337.html

SOURCE AAK AB

Posted on

Veeva Vault PromoMats to Support Bristol Myers Squibb in Speeding Compliant Content to Market Engagement

Veeva Vault PromoMats to Support Bristol Myers Squibb in Speeding Compliant Content to Market Engagement

Vault PromoMats automates submission-ready promotional materials to meet latest FDA eCTD requirements

BARCELONA, Spain–(BUSINESS WIRE)–Veeva Systems (NYSE: VEEV) today announced that Bristol Myers Squibb (NYSE: BMY) is adopting Veeva Vault PromoMats to deliver fast, compliant content across all digital channels to meet their customers’ needs. Vault PromoMats will enable Bristol Myers Squibb to automatically generate submission-ready forms for 2253 and accelerated approval products, a new capability planned for availability in December 2020. The leading biopharmaceutical company can significantly reduce time in packaging promotional materials to send via Electronic Common Technical Document (eCTD) to the U.S. Food and Drug Administration.

Adoption of Vault PromoMats builds upon Bristol Myers Squibb’s success with other Veeva Commercial Cloud applications, including Veeva CRM, Veeva CRM Engage Meeting, Veeva CRM Approved Email, Veeva CRM Events Management, and Veeva Vault MedComms. Veeva gives Bristol Myers Squibb the commercial foundation for compliant content and multichannel engagement to drive a more tailored customer experience.

Vault PromoMats is an advanced application that combines digital asset management with medical, legal, and regulatory review to improve global reuse of promotional materials and maintain compliance from content creation through distribution. With Vault PromoMats, Veeva is helping life sciences stay ahead of evolving regulations, including the June 2021 deadline that will require organizations to submit promotional materials electronically with the latest eCTD requirements.

“We’re proud to continue our partnership with Bristol Myers Squibb and help promotional materials get to market efficiently in the face of a growing volume of content, channels, and complexity,” said Pooja Ojala, vice president of commercial content at Veeva. “Veeva is dedicated to product excellence and rapid innovation that helps leaders like Bristol Myers Squibb stay compliant while delivering a more impactful experience for their customers.”

Learn how Vault PromoMats speeds compliant commercial content to market at the upcoming Veeva Commercial & Medical Europe Summit Online, 17-18 Nov., 2020. The online event is open to life sciences industry professionals. Register and see the full agenda at veeva.com/Summit.

Additional Information

Connect with Veeva on LinkedIn: linkedin.com/company/veeva-systems

Follow @veeva_eu on Twitter: twitter.com/veeva_eu

Like Veeva on Facebook: facebook.com/veevasystems

About Veeva Systems

Veeva Systems Inc. is a leader in cloud solutions—including data, software, and services—for the global life sciences industry. Committed to innovation, product excellence, and customer success, Veeva serves more than 900 customers, ranging from the world’s largest pharmaceutical companies to emerging biotechs. The company is headquartered in the San Francisco Bay Area, with offices throughout North America, Europe, Asia, and Latin America. For more information, visit veeva.com/eu.

Forward-looking Statements

This release contains forward-looking statements, including the market demand for and acceptance of Veeva’s products and services, the results from use of Veeva’s products and services, and general business conditions (including the on-going impact of COVID-19), particularly within the life sciences industry. Any forward-looking statements contained in this press release are based upon Veeva’s historical performance and its current plans, estimates, and expectations, and are not a representation that such plans, estimates, or expectations will be achieved. These forward-looking statements represent Veeva’s expectations as of the date of this press announcement. Subsequent events may cause these expectations to change, and Veeva disclaims any obligation to update the forward-looking statements in the future. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially. Additional risks and uncertainties that could affect Veeva’s financial results are included under the captions, “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” in the company’s filing on Form 10-Q for the period ended July 31, 2020. This is available on the company’s website at veeva.com under the Investors section and on the SEC’s website at sec.gov. Further information on potential risks that could affect actual results will be included in other filings Veeva makes with the SEC from time to time.

® 2020 Veeva Systems Inc. All rights reserved. Veeva and the Veeva logo are trademarks of Veeva Systems Inc.

Veeva Systems Inc. owns other registered and unregistered trademarks.

Roger Villareal

Veeva Systems

925-264-8885

[email protected]

KEYWORDS: Spain Europe

INDUSTRY KEYWORDS: Technology Research FDA Software Biotechnology Health Pharmaceutical Data Management Science

MEDIA:

Logo
Logo